Minerva Neurosciences
NERV
NERV
19 hedge funds and large institutions have $2.75M invested in Minerva Neurosciences in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
85% less capital invested
Capital invested by funds: $18.6M → $2.75M (-$15.9M)
Holders
19
Holding in Top 10
–
Calls
$37K
Puts
$87K
Top Buyers
| 1 | +$48.2K | |
| 2 | +$13.5K | |
| 3 | +$1.94K | |
| 4 |
BlackRock
New York
|
+$1.19K |
| 5 |
Millennium Management
New York
|
+$511 |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$261K | |
| 3 | -$231K | |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
-$102K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$53K |